Chicago, Illinois, April 02, 2018 -- The Center for International Law at The John Marshall Law School in Chicago will host its 17th Annual Folsom Lecture on April 4. The topic of the lecture will be “Piercing the Corporate Veil: A European Perspective”.
|
|||
This year’s lecture will be led by Louis-Daniel Muka Tshibende, an associate professor, vice dean in charge of international relations and academic director of two English-taught programs at Lyon Catholic University: LL.M. of International Business Law and University Diploma in Common Law. Tshibende holds an LL.B. in Economic and Social Law from the Protestant University of Congo, an LL.M. in Business Law and a Ph.D. in Private Law from the Aix-Marseille University Faculty of Law and Political Science. His lectures and research focus on comparative law, company law and contract law.
The event will also feature three commentators: Arthur Acevedo, professor of law at The John Marshall Law School; Andre Fiebig, a partner at Quarles & Brady LLP; and Marjorie Loeb, a partner at Mayer Brown. The presentation will address the advantages and disadvantages of the EU and its member states recognizing the corporate veil.
The Folsom Lecture on International Business and Trade Law is an annual event at John Marshall named after Ralph H. Folsom. Folsom is a professor at the University of San Diego School of Law who teaches antitrust law, international business, NAFTA, European Union Law and international trade law. He is also an adjunct faculty member in John Marshall’s LL.M. in International Business and Trade Law program and serves on John Marshall’s Center for International Law Advisory Board. Every spring, Folsom or another noted academic or practitioner lectures on some aspect of international business and trade law. This lecture series was initiated in 2002. Previous lecture topics include “Free Trade vs World Trade,” “Trading for National Security: U.S. Free Trade Agreements in the Middle East and North Africa,” and “WTO Regulation of Bilateral Trade Agreements: A Reform Proposal.”
About The John Marshall Law School
The John Marshall Law School, founded in 1899, is an independent law school located in the heart of Chicago's legal, financial and commercial districts. The 2019 U.S. News & World Report's America's Best Graduate Schools ranks John Marshall's Lawyering Skills Program 6th, its Intellectual Property Law Program 15th and its Trial Advocacy Program 20th in the nation. Since its inception, John Marshall has been a pioneer in legal education and has been guided by a tradition of diversity, innovation, access and opportunity.
Attachment:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/68bad17b-9d4f-4f54-8084-32be7cba3152
Miller McDonald The John Marshall Law School 312.427.2737 [email protected]


Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Anta Sports Expands Global Footprint With Strategic Puma Stake
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Washington Post Publisher Will Lewis Steps Down After Layoffs
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal 



